105 related articles for article (PubMed ID: 15016136)
1. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Bakri RS; Afzali B; Covic A; Sriskantharan R; Bharma-Ariza P; Park WH; Sriharan M; Dalton N; Wierzbicki AS; Crook MA; Goldsmith DJ
Clin Transplant; 2004 Apr; 18(2):201-4. PubMed ID: 15016136
[TBL] [Abstract][Full Text] [Related]
2. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
3. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
4. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
van Ree RM; de Vries AP; Oterdoom LH; The TH; Gansevoort RT; Homan van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2524-31. PubMed ID: 16115856
[TBL] [Abstract][Full Text] [Related]
5. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
8. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
[TBL] [Abstract][Full Text] [Related]
9. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
[TBL] [Abstract][Full Text] [Related]
10. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
13. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
Welsh P; Woodward M; Rumley A; Lowe G
Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
[TBL] [Abstract][Full Text] [Related]
14. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients.
van Ree RM; Oterdoom LH; de Vries AP; Gansevoort RT; van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2007 Jan; 22(1):246-53. PubMed ID: 16998222
[TBL] [Abstract][Full Text] [Related]
16. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
White M; Ross H; Haddad H; LeBlanc MH; Racine N; Pflugfelder P; Giannetti N; Davies R; Azevedo E; Isaac D; Burton J; Ferguson R; Genest J
Transplantation; 2006 Sep; 82(6):763-70. PubMed ID: 17006323
[TBL] [Abstract][Full Text] [Related]
17. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
[TBL] [Abstract][Full Text] [Related]
18. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation].
Krzanowski M; Stompór T; Kuśnierz-Cabala B; Ignacak E; Sułowicz W; Naskalski JW
Przegl Lek; 2006; 63(8):597-601. PubMed ID: 17441364
[TBL] [Abstract][Full Text] [Related]
20. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
